Irinotecan Hydrochloride 55150-0353
Product NDC
55150-0353- Manufacturer
- Eugia Us Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 11, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213278
Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Irinotecan Hydrochloride | 20 mg/mL |
Drug Class
Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (55150-353-01) / 5 mL in 1 VIAL, SINGLE-DOSE